The reprogramming of glutamine metabolism and the dependence of PDAC cells on this non-canonical pathway for supporting pancreatic cancer growth is also contingent on oncogenic K-Ras (Son et al., 2013). The gene discussed is KRAS; the disease is pancreatic neoplasm.